Millennium Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)
07 Avril 2008 - 7:06PM
Edgar (US Regulatory)
UNITED
STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
|
SCHEDULE 14A
|
|
Proxy
Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
|
Filed by the Registrant
x
|
|
Filed by a Party other than the
Registrant
o
|
|
Check the appropriate box:
|
o
|
Preliminary Proxy Statement
|
o
|
Confidential, for
Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
o
|
Definitive Proxy Statement
|
x
|
Definitive Additional Materials
|
o
|
Soliciting Material Pursuant to
§240.14a-12
|
|
Millennium
Pharmaceuticals, Inc
|
(Name
of Registrant as Specified In Its Charter)
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
Payment of Filing Fee (Check the
appropriate box):
|
x
|
No fee required.
|
o
|
Fee computed on table below per
Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to
which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to
which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying
value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth
the amount on which the filing fee is calculated and state how it was
determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of
transaction:
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
o
|
Fee paid previously with preliminary
materials.
|
o
|
Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration
Statement No.:
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
|
|
|
|
|
MR
ANDREW SAMPLE
1234 AMERICA DRIVE
ANYWHERE, IL 60661
IMPORTANT
ANNUAL STOCKHOLDERS MEETING
INFORMATION YOUR VOTE COUNTS!
|
|
|
|
|
Annual Stockholders Meeting Notice
|
123456
|
C0123456789
|
12345
|
|
|
|
|
|
|
Important Notice Regarding the Availability of Proxy
Materials for the
Millennium Pharmaceuticals, Inc. Annual Stockholders Meeting to be Held
on May 22, 2008
Under new Securities and Exchange Commission rules, you are receiving
this notice that the proxy materials for the annual stockholders meeting are
available on the Internet. Follow the instructions below to view the materials
and vote online or request a copy. The items to be voted on and location of the
annual meeting are on the reverse side. Your vote is important!
This communication presents only an overview
of the more complete proxy materials that are available to you on the Internet.
We encourage you to access and review all of the important information
contained in the proxy materials before voting. The proxy statement and annual
report to stockholders are available at:
www.investorvote.com/mlnm
Easy Online Access A Convenient Way to View Proxy
Materials and Vote
When you go online to view materials, you can
also vote your shares.
Step 1:
Go to
www.investorvote.com/mlnm
Step 2:
Click the
View
button(s) to access the proxy
materials.
Step 3:
Return to
the investorvote.com window and follow the instructions on the screen to log
in.
Step 4:
Make your
selection as instructed on each screen to select delivery preferences and vote.
When you go online, you can also help the
environment by consenting to receive electronic delivery of future materials.
Obtaining a Copy of the Proxy Materials If
you want to receive a paper or e-mail copy of these documents, you must request
one. There is no charge to you for requesting a copy. Please make your request
for a copy as instructed on the reverse side on or before May 12, 2008 to
facilitate timely delivery.
|
Annual
Stockholders Meeting Notice
|
|
The
Millennium Pharmaceuticals, Inc. Annual Meeting of Stockholders will be
held on May 22, 2008 at The Charles Hotel, One Bennett Street, Cambridge,
MA 02138, at 10:00 a.m. Eastern Time.
Proposals
to be voted on at the meeting are listed below along with the Board of
Directors recommendations.
The Board
of Directors recommends that you vote
FOR
the following proposals:
1.
|
Elect
ten directors to hold office for a one-year term until the 2009 annual
meeting of stockholders.
|
|
Deborah
Dunsire
Robert F. Friel
|
|
A.
Grant Heidrich, III
Charles J. Homcy
Raju S. Kucherlapati
Jeffrey M. Leiden
Mark J. Levin
|
|
Norman
C. Selby
Kenneth E. Weg
Anthony H. Wild
|
|
|
2.
|
Ratify
the appointment of Ernst & Young LLP as our independent registered
public accounting firm for the fiscal year ending December 31, 2008.
|
|
|
PLEASE NOTE
YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must vote
online as explained in this Notice, or
request a paper copy of the
proxy materials to receive a proxy card. If you wish to attend and vote at the
meeting, please bring this notice with you.
Heres how to order a copy of the proxy
materials and select a future delivery preference:
Paper copies:
Current and future paper delivery requests can be submitted via the
telephone, Internet or email options below.
Email copies:
Current and future email delivery requests must be submitted via the
Internet following the instructions below. If you request an email copy of
current materials you will receive an email with a link to the materials.
PLEASE NOTE:
You must use the numbers in the shaded bar on the reverse side when
requesting a set of proxy materials.
·
Internet
Go to
www.investorvote.com/mlnm.
Follow the instructions to log in and order a paper or email copy of
the current meeting materials and submit your preference for email or paper
delivery of future meeting materials.
·
Telephone
Call us free of charge at 1-866-641-4276
using a touch-tone phone and follow the instructions to log in and order a
paper copy of the materials by mail for the current meeting. You can also
submit a preference to receive a paper copy for future meetings.
·
Email
Send email to investorvote@computershare.com
with Proxy Materials Millennium in the subject line. Include in the message
your full name and address, plus the three numbers located in the shaded bar on
the reverse, and state in the email that you want a paper copy of current
meeting materials. You can also state your preference to receive a paper copy
for future meetings.
To facilitate timely
delivery, all requests for a paper copy of the proxy materials must be received
by May 12, 2008.
00V6AB
Important Notice Regarding the Availability of Proxy
Materials for the Stockholder Meeting to be held on 05/22/08.
|
This
communication presents only an overview of the more complete proxy materials
that are available to you on the Internet. We encourage you to access and
review all of the important information contained in the proxy materials before
voting.
The following materials are available for
view:
Notice and Proxy
Statement and Annual Report
To view this material, have the 12-digit
Control #(s) available and visit:
www.proxyvote.com
If you want to receive a
paper or e-mail copy of the above listed documents you must request one. There
is no charge to you for requesting a copy.
To facilitate timely
delivery please make the request as instructed below on or before 05/09/08.
To request material:
|
Internet:
www.proxyvote.com
|
Telephone:
1
-
800
-
579
-
1639
|
**Email:
sendmaterial@proxyvote.com
|
**If requesting material by
e-mail please send a blank e-mail with the
12
Digit Control# (located on the following page)
in the subject line.
Requests, instructions and other inquiries will NOT be forwarded to your
investment advisor.
MILLENNIUM PHARMACEUTICALS, INC.
Should you choose to vote these shares in person at
the meeting you must request a legal proxy. To request a legal proxy please follow
the instructions at www.proxyvote.com or request a paper copy of the material.
Many stockholder meetings have attendance requirements including, but not
limited to, the possession of an attendance ticket issued by the entity holding
the meeting. Please check the meeting materials for any special requirements
for meeting attendance.
To vote
now
by
Internet
, go to
WWW.PROXYVOTE.COM
.
Please refer to the
proposals and follow the
instructions
.
Meeting Type:
|
Annual
|
|
Meeting Location:
|
The Charles Hotel
|
Meeting Date:
|
05/22/08
|
|
|
One Bennett Street
|
Meeting Time:
|
10:00 A.M.
|
|
|
Cambridge, MA 02138
|
For holders as of:
|
03/25/08
|
|
|
|
The Board of Directors
recommends a vote FOR each of Proposals 1 and 2.
1.
Elect
ten directors to hold office for a one-year term until the 2009 annual meeting
of stockholders.
Nominees:
01) Deborah Dunsire
|
|
06) Jeffrey M. Leiden
|
02) Robert F. Friel
|
|
07) Mark J. Levin
|
03) A. Grant
Heidrich, III
|
|
08) Norman C. Selby
|
04) Charles J. Homcy
|
|
09) Kenneth E. Weg
|
05) Raju S. Kucherlapati
|
|
10) Anthony H. Wild
|
2.
Ratify
the appointment of Ernst & Young LLP as our independent registered
public accounting firm for the fiscal year ending December 31, 2008.
Millennium Pharmaceuticals (MM) (NASDAQ:MLNM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Millennium Pharmaceuticals (MM) (NASDAQ:MLNM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024